0001209191-18-057432.txt : 20181106
0001209191-18-057432.hdr.sgml : 20181106
20181106170156
ACCESSION NUMBER: 0001209191-18-057432
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181102
FILED AS OF DATE: 20181106
DATE AS OF CHANGE: 20181106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAGUSA ROBERT P
CENTRAL INDEX KEY: 0001222644
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 181163831
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-02
0
0001581280
Twist Bioscience Corp
TWST
0001222644
RAGUSA ROBERT P
C/O TWIST BIOSCIENCE CORPORATION
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO
CA
94158
1
0
0
0
Common Stock
2018-11-02
4
C
0
542203
A
542203
I
By Illumina, Inc.
Common Stock
2018-11-02
4
C
0
329305
A
871508
I
By Illumina, Inc.
Common Stock
2018-11-02
4
C
0
673378
A
1544886
I
By Illumina, Inc.
Common Stock
2018-11-02
4
C
0
157215
A
1702101
I
By Illumina, Inc.
Common Stock
0
D
Series A Preferred Stock
2018-11-02
4
C
0
542203
0.00
D
Common Stock
542203
0
I
By Illumina, Inc.
Series B Preferred Stock
2018-11-02
4
C
0
329305
0.00
D
Common Stock
329305
0
I
By Illumina, Inc.
Series C Preferred Stock
2018-11-02
4
C
0
673378
0.00
D
Common Stock
673378
0
I
By Illumina, Inc.
Series D Preferred Stock
2018-11-02
4
C
0
157215
0.00
D
Common Stock
157215
0
I
By Illumina, Inc.
The Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock have no expiration date and converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering.
The Reporting Person is the Senior Vice President, Global Quality and Operations of Illumina, Inc. and has sole voting and dispositive power over the shares held of record by Illumina, Inc. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.
/s/ William Solis, as Attorney-in-Fact
2018-11-06